Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > All Quiet on the TLT Front...
View:
Post by gojotv! on Apr 26, 2021 10:32am

All Quiet on the TLT Front...

Though RDW's been buying lately...
I wonder if the many new test sites are ramping up the study and news is leaking out...
FDA has fast-tracked us...
Now, can we achieve "breakthrough" status in a timely manner?
Enjoy the silence!
Comment by robertshaw on Apr 26, 2021 10:54am
https://www.ic.gc.ca/eic/site/063.nsf/eng/98218.html This "promising candidate..." what the government gazete refers is us... Even Blowjobjoe's bosses know that...,
Comment by greaterfoolFred on Apr 26, 2021 11:44am
Get a grip you guys.  I will be pleasantly surprised if any of the US sites have done any treatments; the tech. has to be set up first and that is very hard to do these days.  And as far as animal testing of a vaccine...get real.  First you have to develop the vaccine.  Our tech is just a tool to kill candidate viruses.  It's only one step in a long process.  What ...more  
Comment by fredgoodwinson on Apr 26, 2021 12:05pm
IMHO it will be whether 13 & 14 have exhibited 90-day CRs to start their clocks ticking. Something of an acid test and should certainly be in the Quarterly.
Comment by StevenBirch on Apr 26, 2021 12:56pm
I agree Fred, an update on 13 & 14 is what we are really looking for here. Anything else is a bonus.
Comment by Oilminerdeluxe on Apr 26, 2021 3:43pm
When might the Quarterly turn up? Would not mind 13 and 14 being healthy at all.
Comment by 99942Apophis on Apr 26, 2021 2:48pm
greaterfoolFred wrote Get a grip you guys.  I will be pleasantly surprised if any of the US sites have done any treatments; the tech. has to be set up first and that is very hard to do these days.  And as far as animal testing of a vaccine...get real.  First you have to develop the vaccine.  Our tech is just a tool to kill candidate viruses.  It's only one step in a ...more  
Comment by enriquesuave on Apr 26, 2021 3:06pm
I agree Apophis.  Video conferencing or Zoom could be done for training the training involves using regular Urological instruments and techniques. Drug instillation is same for all drugs done with a catheter. A flexible cystoscope is routine. The only added feature is how to pass the fibre optic device thrust the working channel of the cystoscope and maintaining maximum bladder volume during ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250